Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
Financials (USD)
Sales 2020 | 1.36M | Sales 2021 | 1.64M | Capitalization | 66.64M |
---|---|---|---|---|---|
Net income 2020 | -43M | Net income 2021 | -33M | EV / Sales 2020 | 50.8 x |
Net cash position 2020 | 55.9M | Net cash position 2021 | 19.96M | EV / Sales 2021 | 28.4 x |
P/E ratio 2020 |
-2.18
x | P/E ratio 2021 |
-2.4
x | Employees | 74 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 52 | 07-02-28 | |
Girish Aakalu
PRN | Corporate Officer/Principal | - | 18-12-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 14-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.000001 | 0.00% | 3 000 |
Delayed Quote OTC Markets, April 23, 2024 at 10:09 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 58 | |
+3.46% | 42.11B | |
+48.83% | 40.08B | |
+8.66% | 40B | |
-10.82% | 26.87B | |
+8.21% | 24.58B | |
-23.50% | 18.44B | |
+2.06% | 11.94B | |
+34.19% | 11.66B | |
+7.50% | 11.01B |
- Stock Market
- Equities
- GNCAQ Stock